About GHICL
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at GHICL
During the past decade, GHICL conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "GHICL"
#1 collaborator was "Ministry of Health, France" with 2 trials as a collaborator and "Institut National de la Santé Et de la Recherche Médicale, France" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at GHICL
According to Clinical.Site data, the most researched conditions in "GHICL" are
"Allergy" (1 trials), "Atrial Fibrillation" (1 trials), "Clinically Isolated Syndrome" (1 trials), "Elderly" (1 trials) and "Geriatric Disorder" (1 trials). Many other conditions were trialed in "GHICL" in a lesser frequency.
Clinical Trials Intervention Types at GHICL
Most popular intervention types in "GHICL" are "Drug" (3 trials), "Device" (2 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Apixaban 5 MG" (1 trials), "CEFAR Primo Pro (TENS device)" (1 trials), "Ketamine" (1 trials), "Reduction in the duration of antibiotic therapy 3 weeks or 6 weeks" (1 trials) and "Tear collection and lumbar punction" (1 trials). Other intervention names were less common.
Clinical Trials Genders at GHICL
The vast majority of trials in "GHICL" are
8 trials for "All" genders.
Clinical Trials Status at GHICL
Currently, there are NaN active trials in "GHICL".
1 are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in GHICL,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in GHICL, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 3 trials that are defined as “Not Applicable".